Skip to main content

Congratulations to Dr Kassouf for his first CCTG GI study enrollment

Congratulations to Dr Kassouf for his first GI CCTG enrolment

CCTG GI committee extends warm congratulations to Dr Elie Kassouf who has enrolled his first patient to the CRC.10 study.

 

Dr Elie Kassouf is a hematologist and medical oncologist at the Jewish General Hospital in Montreal, and an Assistant Professor in the Gerald Bronfman Department of Oncology at McGill University. After a decade practicing across the full range of tumour sites and benign and malignant hematology, he has now dedicated his career to gastrointestinal oncology. He is active in clinical research, as principal investigator and co-investigator on trials across all phases of clinical development. His main interests revolve around improving access to clinical trials and new therapies, as well as integrating new technologies and artificial intelligence in cancer care.

 

From everyone at CCTG, thank you for your contributions and we all look forward to future collaborations.

 

 

About the CRC.10 trial:

Researchers are leveraging new technology to identify tiny amounts of cancer cell DNA in the blood (circulating tumour DNA – ctDNA) as an indicator of the presence of otherwise undetectable numbers of residual colon cancer cells after surgical removal of the main tumour. The goal of the research is to determine whether and how using this information about the presence or absence of ctDNA may allow them to make better decisions about what kind and amount of chemotherapy to recommend to patients after surgery for colon cancer.